Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 365

Which companies will do well in the turmoil of 2020?

The upcoming August 2020 reporting season will be one of the more difficult for listed companies with lock-downs and travel bans seeing sharp and unexpected falls in revenue. Uncertainty as to when economies globally will open up and the impact of high unemployment make it difficult for companies to forecast future profits.

This season will be the toughest since 2008, though probably not as bad as 1992, which was the last time the Australian unemployment rate was above 10%. In 1992 Westpac came close to going under and ANZ Bank recorded a $1 billion loss in the aftermath of the early 1990s property crash and bad loans to 1980s entrepreneurs.

However, reporting season won’t be uniformly grim for Australian companies. In this piece we are going to look at the few potential bright spots in upcoming profit reporting season.

Hardware therapy

The quarantining associated with Covid-19 has seen a significant increase in consumers staying home with time to fix household jobs that could more easily be put off on weekends when family commitments, outings and sports beckon. The Covid-19 crisis has been a boon for industries such as pest exterminators, with house-bound workers more aware of spider, cockroach and ant issues that become more urgent when reported in real-time by one’s spouse.

Similarly, hardware stores have seen solid sales as individuals with time on their hands tackled postponed DIY projects. In early June, Wesfarmers (ASX:WES) reported that sales were up +19% in 2020, a significant gain for a company that dominates Australian hardware with a market share of over 50%. Wesfarmers also benefited from working from home during Covid-19 with their Officeworks division seeing sales up +28% in 2020 as printers, stationery and computers flew out the door.

Staying home with electronics

Electrical retailers JB Hi-Fi (ASX:JBH) and Harvey Norman (ASX:HVN) were deemed ‘essential services’ during the Covid-19 lockdown. Foot traffic in their stores was as busy as supermarkets, despite operating in shopping centres with most other retailers closed.

I visited JB Hi-Fi several times to buy electronic devices, computer games, and products to boost my home wi-fi that was struggling to accommodate two working adults and three home-learning children. In 2020 JB Hi-Fi reported sales growth of 20%, a solid outcome given 10 of the company’s 303 stores had been closed. Also, the company reported that its white-goods focused chain the Good Guys saw sales up +24%, indicating that consumers were diverting funds typically spent on travel to improving their home environment.

Avoiding public transport

While toll road owner Transurban (ASX:TCL) has not benefited from Covid-19, unlike other ‘travel stocks’ it has recovered far quicker than expected from the shut down in the economy. In March the media painted a doomsday scenario for Transurban, with roads empty for months due to social distancing – similar to what Sydney Airport Holdings (ASX:SYD) is now experiencing with passenger volumes still at 3% of the monthly average seen in 2019.

Traffic did fall in late March and early April but has recovered sharply to around 80% of pre-Covid-19 volumes, with many commuters choosing to drive to work rather than use public transport. Heavy vehicle traffic that attracts 3 times the tolls compared to cars barely fell during Covid-19, as construction continued and online shopping supported traffic numbers. Indeed in Sydney, the average daily volume of trucks on Transurban’s Sydney toll roads is now above where they were in February 2020.

Food glorious food

Grocers Woolworths (ASX:WOW), Metcash (ASX:MTS) and Coles (ASX:COL) have seen record sales growth in 2020 as quarantining, restaurant closures, and hoarding of staples saw shoppers flock to their supermarkets. Similarly, without pubs and restaurants open for business bottle shops were deemed an ‘essential service’, with Woolworths’ BWS and Coles’ Liquorland being the sole port of call for the nation’s drinkers. In March, Coles placed a daily purchase limit of either a case of beer or three bottles of wine.

In 2020 Woolworths reported supermarket sales growth of 10% and liquor sales up +15%. This is impressive growth for a company that, due to the size of its market share, generally is only able to grow sales at around Australian GDP growth. However for Woolworths, 2020 earnings are projected to match last years. Higher sales will likely be offset by increased costs to serve customers, as well as the impact of the company’s 294 hotels being closed.

As restrictions ease and restaurants re-open, this sales growth is likely to moderate. It is worth noting that historically, higher levels of unemployment have had a positive impact for grocery sales, as more price-conscious consumers cook at home rather than visiting restaurants and cafes.

Blood from a stone

Biotherapy company CSL (ASX:CSL) which is the second-largest company on the ASX, sells life-saving medical products and vaccines that are generally unaffected by economic cycles. However, unlike other pharmaceutical companies such as Merck or Pfizer, CSL’s products are derived from blood plasma sourced from donors. This is different from giving blood as a large amount of blood is removed from the donor, the blood plasma separated in a centrifuge, and then the protein-depleted blood is returned to the donor.

Around 70% of the global blood plasma is sourced from donors in the USA which, unlike Australia, allows companies to pay donors around $50 a visit to collect blood plasma. Due to social distancing and the wider impacts of the pandemic in the US, we would expect CSL’s collections to be down in 2020, thus impacting earnings in 2021. However rising US unemployment is likely to result in increasing collections over the next few years. During the GFC, CSL saw both higher volumes of plasma being collected through their network of 200+ centres and reduced the payment for donations.

Services going unused

As a result of lockdowns across Australia, there has been a significant decline in hospital admissions, as elective surgery is deferred and the number of accidents has decreased. In May, private hospital surgical admissions fell by 21% (vs long term average of +2.4%) reflecting the impact of the COVID-19 slowdown. With hospital admissions down meaningfully in 2020 and private health insurance premiums paid upfront, private health insurers NIB (ASX:NHF) and Medibank Private (ASX:MPL) should show solid profit growth for 2020 in August. However, this earnings tailwind should begin to reverse as delayed elective surgery is rescheduled for 2021.

Similarly, motor vehicle insurers Suncorp (ASX:SUN) and IAG (ASX:IAG) will see higher earnings in 2020 from a fall in motor vehicle accidents. In May Suncorp reported a 25% decline in motor vehicle claims from March to June, mirroring the 15% reduction (or 77 fewer deaths) in the national road toll in 2020 compared with first five months of 2019. Additionally, we would be very surprised if insurance claims related to crime were not meaningfully down on 2019, an empty house is far more attractive to burglars than one filled with quarantined householders!

Conclusion on winners and losers

While the shutting down of Australia’s borders to international travellers and quarantine measures will be damaging to certain sectors of the economy, it is not uniformly negative for all companies. Australians actually spend more on international travel than international travellers spend here. According to Austrade, in 2019 Australians took 9.9 million international trips spending A$63 billion, whereas foreign tourists spent only $47 billion in Australia. With international travel bans likely to be extended into 2021, a portion of the expenditure previously benefiting hotels and merchants in Bali, Whistler and Tuscany are likely to be spent on home improvement and entertainment as well as domestic travel.

 

Hugh Dive is Chief Investment Officer of Atlas Funds Management. This article is for general information only and does not consider the circumstances of any investor.

 

RELATED ARTICLES

Why August company reporting season was poor

Compare the pair: Expensive versus cheap

How we have invested during COVID-19

banner

Most viewed in recent weeks

Are LICs licked?

LICs are continuing to struggle with large discounts and frustrated investors are wondering whether it’s worth holding onto them. This explains why the next 6-12 months will be make or break for many LICs.

Retirement income expectations hit new highs

Younger Australians think they’ll need $100k a year in retirement - nearly double what current retirees spend. Expectations are rising fast, but are they realistic or just another case of lifestyle inflation?

Welcome to Firstlinks Edition 627 with weekend update

This week, I got the news that my mother has dementia. It came shortly after my father received the same diagnosis. This is a meditation on getting old and my regrets in not getting my parents’ affairs in order sooner.

  • 4 September 2025

5 charts every retiree must see…

Retirement can be daunting for Australians facing financial uncertainty. Understand your goals, longevity challenges, inflation impacts, market risks, and components of retirement income with these crucial charts.

Why super returns may be heading lower

Five mega trends point to risks of a more inflation prone and lower growth environment. This, along with rich market valuations, should constrain medium term superannuation returns to around 5% per annum.

Super crosses the retirement Rubicon

Australia's superannuation system faces a 'Rubicon' moment, a turning point where the focus is shifting from accumulation phase to retirement readiness, but unfortunately, many funds are not rising to the challenge.

Latest Updates

Investment strategies

Why I dislike dividend stocks

If you need income then buying dividend stocks makes perfect sense. But if you don’t then it makes little sense because it’s likely to limit building real wealth. Here’s what you should do instead.

Superannuation

Meg on SMSFs: Indexation of Division 296 tax isn't enough

Labor is reviewing the $3 million super tax's most contentious aspects: lack of indexation and the tax on unrealised gains. Those fighting for change shouldn’t just settle for indexation of the threshold.

Shares

Will ASX dividends rise over the next 12 months?

Market forecasts for ASX dividend yields are at a 30-year low amid fears about the economy and the capacity for banks and resource companies to pay higher dividends. This pessimism seems overdone.

Shares

Expensive market valuations may make sense

World share markets seem toppy at first glance, though digging deeper reveals important nuances. While the top 2% of stocks are pricey, they're also growing faster, and the remaining 98% are inexpensive versus history.

Fixed interest

The end of the strong US dollar cycle

The US dollar’s overvaluation, weaker fundamentals, and crowded positioning point to further downside. Diversifying into non-US equities and emerging market debt may offer opportunities for global investors.

Investment strategies

Today’s case for floating rate notes

Market volatility and uncertainty in 2025 prompt the need for a diversified portfolio. Floating Rate Notes offer stability, income, and protection against interest rate risks, making them a valuable investment option.

Strategy

Breaking down recent footy finals by the numbers

In a first, 2025 saw AFL and NRL minor premiers both go out in straight sets. AFL data suggests the pre-finals bye is weakening the stranglehold of top-4 sides more than ever before.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.